JP2008541009A - サンプルの採取および分析のための装置および方法 - Google Patents

サンプルの採取および分析のための装置および方法 Download PDF

Info

Publication number: JP2008541009A
Authority: JP; Japan
Prior art keywords: sample; collection; card; orifice; analyte
Prior art date: 2005-04-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2008508056A

Other languages

English (en)

Japanese (ja)

Other versions

JP2008541009A5 (fr

Inventor

ダイ，ジエリン

フウ，ハイポン

リヤオ，フエイアル

ユウ，ウエイドン

スン，シヤオミン

Original Assignee

オークビル・ホンコン・カンパニー・リミテツド

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-30

Filing date

2006-04-26

Publication date

2008-11-20

2005-04-30 Priority claimed from CN 200510070353 external-priority patent/CN1760672B/zh

2005-04-30 Priority claimed from US11/119,528 external-priority patent/US8062901B2/en

2006-04-26 Application filed by オークビル・ホンコン・カンパニー・リミテツド filed Critical オークビル・ホンコン・カンパニー・リミテツド

2008-11-20 Publication of JP2008541009A publication Critical patent/JP2008541009A/ja

2009-06-18 Publication of JP2008541009A5 publication Critical patent/JP2008541009A5/ja

Status Pending legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 33
238000004458 analytical method Methods 0.000 title abstract description 8
238000012360 testing method Methods 0.000 claims abstract description 105
239000012491 analyte Substances 0.000 claims abstract description 77
238000003556 assay Methods 0.000 claims abstract description 61
238000003032 molecular docking Methods 0.000 claims abstract description 47
239000012530 fluid Substances 0.000 claims abstract description 33
102000001554 Hemoglobins Human genes 0.000 claims abstract description 21
108010054147 Hemoglobins Proteins 0.000 claims abstract description 21
238000005070 sampling Methods 0.000 claims abstract description 12
239000000523 sample Substances 0.000 claims description 231
238000012546 transfer Methods 0.000 claims description 83
239000000463 material Substances 0.000 claims description 79
239000000872 buffer Substances 0.000 claims description 66
-1 polyethylene Polymers 0.000 claims description 55
239000003153 chemical reaction reagent Substances 0.000 claims description 52
239000002250 absorbent Substances 0.000 claims description 51
230000002745 absorbent Effects 0.000 claims description 51
230000009870 specific binding Effects 0.000 claims description 30
239000011324 bead Substances 0.000 claims description 29
239000004094 surface-active agent Substances 0.000 claims description 27
239000002904 solvent Substances 0.000 claims description 23
239000003480 eluent Substances 0.000 claims description 22
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
239000011734 sodium Substances 0.000 claims description 18
229910052708 sodium Inorganic materials 0.000 claims description 18
229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 17
238000004891 communication Methods 0.000 claims description 17
238000001514 detection method Methods 0.000 claims description 17
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 15
239000011536 extraction buffer Substances 0.000 claims description 13
229920000642 polymer Polymers 0.000 claims description 12
229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 12
239000001267 polyvinylpyrrolidone Substances 0.000 claims description 11
235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 11
239000003755 preservative agent Substances 0.000 claims description 11
229930006000 Sucrose Natural products 0.000 claims description 10
229920001400 block copolymer Polymers 0.000 claims description 10
235000013681 dietary sucrose Nutrition 0.000 claims description 10
229930182478 glucoside Natural products 0.000 claims description 10
229960004793 sucrose Drugs 0.000 claims description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
239000012472 biological sample Substances 0.000 claims description 9
239000011159 matrix material Substances 0.000 claims description 9
230000002335 preservative effect Effects 0.000 claims description 9
238000007789 sealing Methods 0.000 claims description 9
239000002202 Polyethylene glycol Substances 0.000 claims description 8
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 8
239000007788 liquid Substances 0.000 claims description 8
229920001223 polyethylene glycol Polymers 0.000 claims description 8
229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 7
239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 7
229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 7
239000004372 Polyvinyl alcohol Substances 0.000 claims description 7
239000001768 carboxy methyl cellulose Substances 0.000 claims description 7
235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 7
229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 7
239000001863 hydroxypropyl cellulose Substances 0.000 claims description 7
235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 7
239000004816 latex Substances 0.000 claims description 7
229920000126 latex Polymers 0.000 claims description 7
XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 7
229920003023 plastic Polymers 0.000 claims description 7
239000004033 plastic Substances 0.000 claims description 7
229920002451 polyvinyl alcohol Polymers 0.000 claims description 7
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 6
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 6
108010076119 Caseins Proteins 0.000 claims description 6
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 6
108010010803 Gelatin Proteins 0.000 claims description 6
108010058846 Ovalbumin Proteins 0.000 claims description 6
239000004793 Polystyrene Substances 0.000 claims description 6
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 6
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 6
235000010418 carrageenan Nutrition 0.000 claims description 6
229920001525 carrageenan Polymers 0.000 claims description 6
239000005018 casein Substances 0.000 claims description 6
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 6
235000021240 caseins Nutrition 0.000 claims description 6
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 claims description 6
229940043264 dodecyl sulfate Drugs 0.000 claims description 6
229920000159 gelatin Polymers 0.000 claims description 6
239000008273 gelatin Substances 0.000 claims description 6
235000019322 gelatine Nutrition 0.000 claims description 6
235000011852 gelatine desserts Nutrition 0.000 claims description 6
FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 6
229940092253 ovalbumin Drugs 0.000 claims description 6
239000008363 phosphate buffer Substances 0.000 claims description 6
229920000728 polyester Polymers 0.000 claims description 6
229920002223 polystyrene Polymers 0.000 claims description 6
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 6
229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 6
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 6
NLEBIOOXCVAHBD-YHBSTRCHSA-N (2r,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-dodecoxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](OCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NLEBIOOXCVAHBD-YHBSTRCHSA-N 0.000 claims description 5
JYCQQPHGFMYQCF-UHFFFAOYSA-N 4-tert-Octylphenol monoethoxylate Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCO)C=C1 JYCQQPHGFMYQCF-UHFFFAOYSA-N 0.000 claims description 5
108091003079 Bovine Serum Albumin Proteins 0.000 claims description 5
229920002125 Sokalan® Polymers 0.000 claims description 5
239000004699 Ultra-high molecular weight polyethylene Substances 0.000 claims description 5
229960000686 benzalkonium chloride Drugs 0.000 claims description 5
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 5
239000002981 blocking agent Substances 0.000 claims description 5
229940098773 bovine serum albumin Drugs 0.000 claims description 5
229920002678 cellulose Polymers 0.000 claims description 5
239000001913 cellulose Substances 0.000 claims description 5
SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 claims description 5
125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 5
CGVLVOOFCGWBCS-RGDJUOJXSA-N n-octyl β-d-thioglucopyranoside Chemical compound CCCCCCCCS[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CGVLVOOFCGWBCS-RGDJUOJXSA-N 0.000 claims description 5
229920002113 octoxynol Polymers 0.000 claims description 5
HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 claims description 5
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 5
229920000785 ultra high molecular weight polyethylene Polymers 0.000 claims description 5
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 4
239000004677 Nylon Substances 0.000 claims description 4
239000004698 Polyethylene Substances 0.000 claims description 4
239000004743 Polypropylene Substances 0.000 claims description 4
229920001577 copolymer Polymers 0.000 claims description 4
229940091348 latex Drugs 0.000 claims description 4
229920001778 nylon Polymers 0.000 claims description 4
XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims description 4
XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 claims description 4
229920000573 polyethylene Polymers 0.000 claims description 4
229920001155 polypropylene Polymers 0.000 claims description 4
235000015424 sodium Nutrition 0.000 claims description 4
JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 claims description 4
239000003381 stabilizer Substances 0.000 claims description 4
239000000080 wetting agent Substances 0.000 claims description 4
ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims description 3
CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 claims description 3
XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 claims description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 3
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
150000004996 alkyl benzenes Chemical class 0.000 claims description 3
150000001412 amines Chemical class 0.000 claims description 3
239000000679 carrageenan Substances 0.000 claims description 3
229940113118 carrageenan Drugs 0.000 claims description 3
239000004359 castor oil Substances 0.000 claims description 3
235000019438 castor oil Nutrition 0.000 claims description 3
DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 claims description 3
239000003085 diluting agent Substances 0.000 claims description 3
239000004205 dimethyl polysiloxane Substances 0.000 claims description 3
235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 claims description 3
YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 claims description 3
LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 3
238000010828 elution Methods 0.000 claims description 3
SUHUKEQAOUOUJO-UHFFFAOYSA-N ethane-1,2-diol;2,4,7,9-tetramethyldec-5-yne-4,7-diol Chemical compound OCCO.CC(C)CC(C)(O)C#CC(C)(O)CC(C)C SUHUKEQAOUOUJO-UHFFFAOYSA-N 0.000 claims description 3
229940012017 ethylenediamine Drugs 0.000 claims description 3
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
230000013011 mating Effects 0.000 claims description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 3
229940055577 oleyl alcohol Drugs 0.000 claims description 3
XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims description 3
229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
229920002557 polyglycidol polymer Polymers 0.000 claims description 3
229920001343 polytetrafluoroethylene Polymers 0.000 claims description 3
239000004810 polytetrafluoroethylene Substances 0.000 claims description 3
239000004814 polyurethane Substances 0.000 claims description 3
229920002635 polyurethane Polymers 0.000 claims description 3
229940035044 sorbitan monolaurate Drugs 0.000 claims description 3
239000000600 sorbitol Substances 0.000 claims description 3
239000011975 tartaric acid Substances 0.000 claims description 3
235000002906 tartaric acid Nutrition 0.000 claims description 3
229940095064 tartrate Drugs 0.000 claims description 3
229940104261 taurate Drugs 0.000 claims description 3
UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims description 2
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 2
239000002253 acid Substances 0.000 claims description 2
239000003613 bile acid Substances 0.000 claims description 2
239000007853 buffer solution Substances 0.000 claims description 2
239000003795 chemical substances by application Substances 0.000 claims description 2
238000007705 chemical test Methods 0.000 claims description 2
230000000295 complement effect Effects 0.000 claims description 2
229920001519 homopolymer Polymers 0.000 claims description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 1
KFDLHDGFDLHFRW-UHFFFAOYSA-N [O-][N+](Br)=O Chemical compound [O-][N+](Br)=O KFDLHDGFDLHFRW-UHFFFAOYSA-N 0.000 claims 1
238000010521 absorption reaction Methods 0.000 claims 1
150000001540 azides Chemical class 0.000 claims 1
229910052744 lithium Inorganic materials 0.000 claims 1
UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims 1
229920000058 polyacrylate Polymers 0.000 claims 1
229910000104 sodium hydride Inorganic materials 0.000 claims 1
239000012312 sodium hydride Substances 0.000 claims 1
239000007787 solid Substances 0.000 abstract description 6
210000004369 blood Anatomy 0.000 abstract description 4
239000008280 blood Substances 0.000 abstract description 4
230000002550 fecal effect Effects 0.000 abstract 1
229920004890 Triton X-100 Polymers 0.000 description 14
230000027455 binding Effects 0.000 description 13
239000000126 substance Substances 0.000 description 11
239000000123 paper Substances 0.000 description 10
108090000623 proteins and genes Proteins 0.000 description 9
235000018102 proteins Nutrition 0.000 description 8
102000004169 proteins and genes Human genes 0.000 description 8
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 8
238000003018 immunoassay Methods 0.000 description 7
238000007689 inspection Methods 0.000 description 7
150000001875 compounds Chemical class 0.000 description 6
102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
229920001983 poloxamer Polymers 0.000 description 5
229920000136 polysorbate Polymers 0.000 description 5
239000000243 solution Substances 0.000 description 5
230000008901 benefit Effects 0.000 description 4
239000000306 component Substances 0.000 description 4
238000001035 drying Methods 0.000 description 4
UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 4
230000033001 locomotion Effects 0.000 description 4
230000009471 action Effects 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
230000015556 catabolic process Effects 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
230000006870 function Effects 0.000 description 3
230000014509 gene expression Effects 0.000 description 3
230000036541 health Effects 0.000 description 3
239000005556 hormone Substances 0.000 description 3
229940088597 hormone Drugs 0.000 description 3
238000011534 incubation Methods 0.000 description 3
230000003993 interaction Effects 0.000 description 3
229910052751 metal Inorganic materials 0.000 description 3
239000002184 metal Substances 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 2
RHDMCDPPAAUUMD-UHFFFAOYSA-N 6-[4-[2-(dimethylamino)ethoxy]phenyl]-n-(1,3-dithiolan-2-ylmethyl)-5-phenyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine Chemical compound C1=CC(OCCN(C)C)=CC=C1C1=C(C=2C=CC=CC=2)C2=C(NCC3SCCS3)N=CN=C2N1 RHDMCDPPAAUUMD-UHFFFAOYSA-N 0.000 description 2
BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
241000147041 Guaiacum officinale Species 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
229920002593 Polyethylene Glycol 800 Polymers 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
229920002359 Tetronic® Polymers 0.000 description 2
239000000443 aerosol Substances 0.000 description 2
230000008859 change Effects 0.000 description 2
230000002860 competitive effect Effects 0.000 description 2
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
239000002274 desiccant Substances 0.000 description 2
238000013461 design Methods 0.000 description 2
235000013305 food Nutrition 0.000 description 2
239000011491 glass wool Substances 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
239000010931 gold Substances 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
229940091561 guaiac Drugs 0.000 description 2
238000002372 labelling Methods 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
238000012545 processing Methods 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
ORLFVWPPBMVPNZ-UHFFFAOYSA-N 1-(6-methylheptyl)-4-[4-(6-methylheptyl)phenoxy]benzene Chemical compound C1=CC(CCCCCC(C)C)=CC=C1OC1=CC=C(CCCCCC(C)C)C=C1 ORLFVWPPBMVPNZ-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
241000193755 Bacillus cereus Species 0.000 description 1
241000589876 Campylobacter Species 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
206010008631 Cholera Diseases 0.000 description 1
241000193163 Clostridioides difficile Species 0.000 description 1
241000193468 Clostridium perfringens Species 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
241001646719 Escherichia coli O157:H7 Species 0.000 description 1
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
102000006771 Gonadotropins Human genes 0.000 description 1
108010086677 Gonadotropins Proteins 0.000 description 1
241000590002 Helicobacter pylori Species 0.000 description 1
241000282412 Homo Species 0.000 description 1
241000186779 Listeria monocytogenes Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
241000607768 Shigella Species 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
229920010741 Ultra High Molecular Weight Polyethylene (UHMWPE) Polymers 0.000 description 1
241000607626 Vibrio cholerae Species 0.000 description 1
241000607272 Vibrio parahaemolyticus Species 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
238000007605 air drying Methods 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000002280 amphoteric surfactant Substances 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
239000003945 anionic surfactant Substances 0.000 description 1
238000003149 assay kit Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
239000012503 blood component Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
239000003093 cationic surfactant Substances 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
239000013068 control sample Substances 0.000 description 1
229940109239 creatinine Drugs 0.000 description 1
150000001925 cycloalkenes Chemical class 0.000 description 1
238000000151 deposition Methods 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
238000007599 discharging Methods 0.000 description 1
238000002845 discoloration Methods 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
239000000975 dye Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
FYUWIEKAVLOHSE-UHFFFAOYSA-N ethenyl acetate;1-ethenylpyrrolidin-2-one Chemical compound CC(=O)OC=C.C=CN1CCCC1=O FYUWIEKAVLOHSE-UHFFFAOYSA-N 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
239000002657 fibrous material Substances 0.000 description 1
229920002457 flexible plastic Polymers 0.000 description 1
239000011888 foil Substances 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000002622 gonadotropin Substances 0.000 description 1
229940094892 gonadotropins Drugs 0.000 description 1
230000005484 gravity Effects 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
229940037467 helicobacter pylori Drugs 0.000 description 1
239000011346 highly viscous material Substances 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000005661 hydrophobic surface Effects 0.000 description 1
238000007654 immersion Methods 0.000 description 1
238000001746 injection moulding Methods 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
239000003446 ligand Substances 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000011068 loading method Methods 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
239000000203 mixture Substances 0.000 description 1
239000002991 molded plastic Substances 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
229920006284 nylon film Polymers 0.000 description 1
ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
239000005022 packaging material Substances 0.000 description 1
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000011087 paperboard Substances 0.000 description 1
244000045947 parasite Species 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000003825 pressing Methods 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
230000010069 protein adhesion Effects 0.000 description 1
238000000751 protein extraction Methods 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
238000001799 protein solubilization Methods 0.000 description 1
230000007925 protein solubilization Effects 0.000 description 1
230000015227 regulation of liquid surface tension Effects 0.000 description 1
230000001846 repelling effect Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
239000012056 semi-solid material Substances 0.000 description 1
NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
239000002689 soil Substances 0.000 description 1
239000011343 solid material Substances 0.000 description 1
125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
239000012209 synthetic fiber Substances 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000002982 water resistant material Substances 0.000 description 1
238000009736 wetting Methods 0.000 description 1
210000002268 wool Anatomy 0.000 description 1

Images

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Tropical Medicine & Parasitology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Sampling And Sample Adjustment (AREA)

JP2008508056A 2005-04-30 2006-04-26 サンプルの採取および分析のための装置および方法 Pending JP2008541009A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CN 200510070353 CN1760672B (zh)	2004-10-12	2005-04-30	样本检测装置和样本检测方法
US11/119,528 US8062901B2 (en)	2005-04-30	2005-04-30	Devices and methods for sample collection and analysis
PCT/CN2006/000806 WO2006116917A2 (fr)	2005-04-30	2006-04-26	Dispositifs et procedes de collecte et d'analyse d'echantillons

Publications (2)

Publication Number	Publication Date
JP2008541009A true JP2008541009A (ja)	2008-11-20
JP2008541009A5 JP2008541009A5 (fr)	2009-06-18

Family

ID=37308334

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2008508056A Pending JP2008541009A (ja)	2005-04-30	2006-04-26	サンプルの採取および分析のための装置および方法

Country Status (5)

Country	Link
JP (1)	JP2008541009A (fr)
DE (1)	DE212006000036U1 (fr)
GB (1)	GB2440470B (fr)
HK (1)	HK1117594A1 (fr)
WO (1)	WO2006116917A2 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2009513966A (ja) *	2005-10-25	2009-04-02	インバーネス・メデイカル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング	試料内のアナライトを検知するための方法およびキット
JP2010519507A (ja) *	2007-02-16	2010-06-03	ワットマンインコーポレイテッド	制御された移転生体試料採取装置およびその装置を使用する方法
JP2013513113A (ja) *	2009-12-04	2013-04-18	ラピッドパトゲンスクリーニング，インク．	サンプル圧縮機を用いた複数面の側方流動アッセイ
JP2014503068A (ja) *	2011-01-05	2014-02-06	コパンイタリアエス．ピー．エー	分子生物学用の試料を採取して移動させるための装置を実現するためのプロセス
JP2014508308A (ja) *	2011-03-18	2014-04-03	ジーイー・ヘルスケア・ユーケイ・リミテッド	生物学的試料を保存するための装置
JP2017502270A (ja) *	2013-12-13	2017-01-19	ゼネラル・エレクトリック・カンパニイ	分析物のフロースルー溶出用試料保存抽出デバイス
WO2017170824A1 (fr) *	2016-03-31	2017-10-05	積水メディカル株式会社	Procédé de détection de fibronectine oncofœtale par dosage immunologique simple
JP2020529606A (ja) *	2017-08-03	2020-10-08	フィブロテックスエー	スキンケアに適用するための側方流動分析及び装置

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2317319A4 (fr) *	2008-06-30	2011-09-07	Sekisui Medical Co Ltd	Phase solide poreuse pour essai de liaison, et procédé d'essai de liaison l'utilisant
CN104411406B (zh)	2012-03-16	2017-05-31	统计诊断与创新有限公司	具有集成传送模块的测试盒
DE102017203234B4 (de)	2017-02-28	2018-11-15	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Mikrobiom-Transplantation
CN115267208B (zh) *	2022-09-27	2023-01-03	上海芯超生物科技有限公司	一种幽门螺旋杆菌抗体检测用抗原、试剂盒及其制备方法
CN116643044B (zh) *	2023-06-15	2023-12-12	广州贝思奇诊断试剂有限公司	一种基于胶体金法检测尿液中hiv-1和hiv-2抗体的试剂盒及其制备方法、应用

Citations (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6388460A (ja) *	1986-09-18	1988-04-19	パシフィック・バイオテック・インコーポレーテッド	免疫診断装置
JPH04232833A (ja) *	1990-07-17	1992-08-21	Boehringer Mannheim Gmbh	ペースト状サンプル中の分析物のための測定具
JPH10132816A (ja) *	1996-10-28	1998-05-22	Nitto Denko Corp	免疫学的検査具
JPH10132820A (ja) *	1996-10-28	1998-05-22	Okuto:Kk	免疫学的検査具
WO1998048280A1 (fr) *	1997-04-24	1998-10-29	Selfcare, Inc.	Dispositif de detection d'une substance dans un echantillon liquide
JP2000512382A (ja) *	1996-06-05	2000-09-19	イーアン・ゲースタ・モリソン・クリートー	便潜血検体のスクリーニング装置及び方法
JP2000356638A (ja) *	1999-06-11	2000-12-26	Nissui Pharm Co Ltd	イムノクロマトグラフィー装置のハウジング
JP2001519531A (ja) *	1997-10-06	2001-10-23	エンテリックスインコーポレイテッド	分析物検出のための装置と方法
JP2002539425A (ja) *	1999-03-11	2002-11-19	エンテリックスインコーポレイテッド	サンプル収集および試験システム
WO2004081541A1 (fr) *	2003-03-14	2004-09-23	Allergenix Limited	Dispositif de dosage
JP2004279157A (ja) *	2003-03-14	2004-10-07	Rohto Pharmaceut Co Ltd	癌病巣判定のためのキット並びに方法
CN1614383A (zh) *	2004-10-12	2005-05-11	艾康生物技术(杭州)有限公司	一种样本收集、检测装置及检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1178578A (zh) *	1995-03-14	1998-04-08	霍华德·M·钱德勒	试样采集装置
US5948687A (en) *	1996-06-05	1999-09-07	Cleator; Iain G.M.	Device and method for screening fecal occult blood specimens
US6436714B1 (en) *	1998-08-11	2002-08-20	Diagnostica, Inc.	Self-contained system and method for testing for fecal occult blood

2006
- 2006-04-26 WO PCT/CN2006/000806 patent/WO2006116917A2/fr active Application Filing
- 2006-04-26 JP JP2008508056A patent/JP2008541009A/ja active Pending
- 2006-04-26 DE DE212006000036U patent/DE212006000036U1/de not_active Expired - Lifetime
2007
- 2007-10-29 GB GB0721125A patent/GB2440470B/en active Active
2008
- 2008-07-24 HK HK08108210.9A patent/HK1117594A1/xx unknown

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6388460A (ja) *	1986-09-18	1988-04-19	パシフィック・バイオテック・インコーポレーテッド	免疫診断装置
JPH04232833A (ja) *	1990-07-17	1992-08-21	Boehringer Mannheim Gmbh	ペースト状サンプル中の分析物のための測定具
JP2000512382A (ja) *	1996-06-05	2000-09-19	イーアン・ゲースタ・モリソン・クリートー	便潜血検体のスクリーニング装置及び方法
JPH10132816A (ja) *	1996-10-28	1998-05-22	Nitto Denko Corp	免疫学的検査具
JPH10132820A (ja) *	1996-10-28	1998-05-22	Okuto:Kk	免疫学的検査具
WO1998048280A1 (fr) *	1997-04-24	1998-10-29	Selfcare, Inc.	Dispositif de detection d'une substance dans un echantillon liquide
JP2001519531A (ja) *	1997-10-06	2001-10-23	エンテリックスインコーポレイテッド	分析物検出のための装置と方法
JP2002539425A (ja) *	1999-03-11	2002-11-19	エンテリックスインコーポレイテッド	サンプル収集および試験システム
JP2000356638A (ja) *	1999-06-11	2000-12-26	Nissui Pharm Co Ltd	イムノクロマトグラフィー装置のハウジング
WO2004081541A1 (fr) *	2003-03-14	2004-09-23	Allergenix Limited	Dispositif de dosage
JP2004279157A (ja) *	2003-03-14	2004-10-07	Rohto Pharmaceut Co Ltd	癌病巣判定のためのキット並びに方法
CN1614383A (zh) *	2004-10-12	2005-05-11	艾康生物技术(杭州)有限公司	一种样本收集、检测装置及检测方法

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2009513966A (ja) *	2005-10-25	2009-04-02	インバーネス・メデイカル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング	試料内のアナライトを検知するための方法およびキット
JP2010519507A (ja) *	2007-02-16	2010-06-03	ワットマンインコーポレイテッド	制御された移転生体試料採取装置およびその装置を使用する方法
JP2013231731A (ja) *	2007-02-16	2013-11-14	Ge Healthcare Bioscience Corp	制御された移転生体試料採取装置およびその装置を使用する方法
JP2013513113A (ja) *	2009-12-04	2013-04-18	ラピッドパトゲンスクリーニング，インク．	サンプル圧縮機を用いた複数面の側方流動アッセイ
JP2014503068A (ja) *	2011-01-05	2014-02-06	コパンイタリアエス．ピー．エー	分子生物学用の試料を採取して移動させるための装置を実現するためのプロセス
JP2014508308A (ja) *	2011-03-18	2014-04-03	ジーイー・ヘルスケア・ユーケイ・リミテッド	生物学的試料を保存するための装置
JP2017502270A (ja) *	2013-12-13	2017-01-19	ゼネラル・エレクトリック・カンパニイ	分析物のフロースルー溶出用試料保存抽出デバイス
WO2017170824A1 (fr) *	2016-03-31	2017-10-05	積水メディカル株式会社	Procédé de détection de fibronectine oncofœtale par dosage immunologique simple
JP6254333B1 (ja) *	2016-03-31	2017-12-27	積水メディカル株式会社	簡易免疫測定を利用した癌胎児性フィブロネクチンの検出方法
JP2020529606A (ja) *	2017-08-03	2020-10-08	フィブロテックスエー	スキンケアに適用するための側方流動分析及び装置

Also Published As

Publication number	Publication date
HK1117594A1 (en)	2009-01-16
GB0721125D0 (en)	2007-12-05
GB2440470A (en)	2008-01-30
GB2440470B (en)	2010-02-24
DE212006000036U1 (de)	2008-02-21
WO2006116917A3 (fr)	2008-02-14
WO2006116917A2 (fr)	2006-11-09

Legal Events

Date	Code	Title	Description
2009-04-23	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090422
2009-04-23	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090422
2011-07-20	A977	Report on retrieval	Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110720
2011-07-27	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110726
2011-10-25	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111024
2011-11-01	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111031
2012-04-04	A02	Decision of refusal	Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120403

Publication	Publication Date	Title
US8062901B2 (en)	2011-11-22	Devices and methods for sample collection and analysis
JP2008541009A (ja)	2008-11-20	サンプルの採取および分析のための装置および方法
US20090117660A1 (en)	2009-05-07	Devices and methods for sample collection and analysis
US20070092401A1 (en)	2007-04-26	Devices and methods for sample collection and analysis
US20090226928A1 (en)	2009-09-10	Method and kit for detecting an analyte in a sample
JP4889498B2 (ja)	2012-03-07	サンプルの高速分析および保存装置、ならびに使用方法
JP5308029B2 (ja)	2013-10-09	分析物を検出するための装置および方法
CN1760672B (zh)	2010-05-12	样本检测装置和样本检测方法
JPH01502054A (ja)	1989-07-13	内蔵式の固相免疫拡散試金のための装置及び方法
US7264776B2 (en)	2007-09-04	Sanitary and compact fecal occult blood collector
US20070202611A1 (en)	2007-08-30	Simple membrane assay method and kit
CN101498717B (zh)	2013-08-28	用于收集固体或者半固体样本的样本收集装置
CA2570383C (fr)	2015-04-14	Dispositif de filtre, procede, kit et utilisation de celui-ci
CN217084994U (zh)	2022-07-29	一种棘球蚴抗体免疫层析检测卡
CN114264816A (zh)	2022-04-01	一种棘球蚴抗体免疫层析试纸条和检测卡
US20220120742A1 (en)	2022-04-21	Devices and methods for lateral flow tests of bodily fluids
CN115819609A (zh)	2023-03-21	一种检测猪全血的胶体金试纸条
JP3717936B6 (ja)	2006-02-22	サンプル収集装置
GB2619127A (en)	2023-11-29	Test device for analyte in a fluid sample
JPH11502018A (ja)	1999-02-16	サンプル収集装置